August 25, 2009 (FinancialWire) — Illumina, Inc.’s (NASDAQ: ILMN) board has approved a new stock repurchase program authorizing the company to repurchase up to $75 million of its outstanding common stock.

The company has terminated a $120 million repurchase program authorized last October after repurchasing an aggregate of $70.7 million of its outstanding common stock in 2008.

According to Illumina, the new purchases will be funded from existing cash balances.

San Diego-based Illumina is a developer, manufacturer, and marketer of life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.